foundation pharm Flashcards
what are the 3 types of antagonists
- competitive antagonist - bind to same binding site as endogenous ligand and compete for the same R
- non-competitive not at receptor - bind to allosteric R –> stops stimulus
- non competitive at receptor - activation of R with opposite effect
the effect of an antagonist depends on:
- the efficacy of the agonist
- the affinity of the antagonist
how does binding to the allosteric site affect the R
- modulation of orthosteric ligand affinity
- modulation of orthosteric ligand efficacy
- modulation of R activation level
what are the advantages of using drugs that bind to the allosteric site
- substantial selectivity between R subtypes
- incomplete antagonism possible
what is surmountable antagonism
antagonism that is able to be overcome
- you can get the response back by increasing the conc of the agonist
what kind of receptor is the beta-adrenoceptor
GPCR
what are the 4 types of receptors
GPCR
ligand gated ion channels
kinase-linked
nuclear
what are the subtypes of nicotinic receptors
NM - muscular
NN - autonomic ganglia
what is the difference between pharmacokinetics and pharmacodynamics
PK - what the body does to the drug
PD - what the drug does to the body
what is the therapeutic windown
the dose between starting to have an effect and toxicity
what is the difference between a full and partial agonist
full - gives maximal effect of activating the R
partial - gives only partial effect of activating the R
what is potency
the smallest amount you can give for an effect
how is potency measured
usually measured by EC50 = half of max
what is efficacy
the strength of the R activation
what are the parts of pharmacokinetics
administration, absorption
distribution
elimination (metabolism, excretion)
(AADME)